You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aβ lowering

Showing 1 - 25 of 2,759
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers

Recruiting
  • Cognitively Normal Older Adults
  • +3 more
  • Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
  • PCP
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Memory Dysfunction, Anxiety, Depression Trial in Zarqa (Thymus vulgaris)

Completed
  • Memory Dysfunction
  • +3 more
  • Thymus vulgaris
  • Zarqa, Jordan
    Faculty of Pharmaceutical Sciences
Aug 9, 2023

Neurodegenerative Diseases Trial in Taichung (Acupuncture)

Not yet recruiting
  • Neurodegenerative Diseases
  • Acupuncture
  • Taichung, Taiwan
    China Medical University Hospital
Apr 20, 2023

Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Matching Placebo (Gantenerumab))

Suspended
  • Alzheimers Disease
  • +2 more
  • Birmingham, Alabama
  • +34 more
Jan 10, 2023

Vascular Cognitive Impairment Trial in Wuhan (Comprehensive intensive intervention)

Recruiting
  • Vascular Cognitive Impairment
  • Comprehensive intensive intervention
  • Wuhan, Hubei, China
    Zhongnan Hospital
Aug 10, 2021

Neuropathology Trial in Montpellier, Poitiers, Toulouse (procedure, behavioral, diagnostic test, other)

Not yet recruiting
  • Neuropathology
  • Polysomnography
  • +6 more
  • Montpellier, France
  • +2 more
Jan 12, 2023

Sleep, Alzheimer Trial in Saint Louis (Suvorexant 20 mg, Placebo)

Recruiting
  • Sleep
  • Alzheimer Disease
  • Suvorexant 20 mg
  • Placebo
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 15, 2022

Alzheimer, MDD Trial in New York, Orangeburg (Escitalopram Oxalate, Placebo)

Recruiting
  • Alzheimer Disease
  • Major Depressive Disorder
  • Escitalopram Oxalate
  • Placebo
  • New York, New York
  • +1 more
Dec 29, 2022

Medicare Anti-Aß mAb Coverage With Evidence Development Study

Recruiting
  • Mild Alzheimer's Disease
  • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
  • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
  • Baltimore, Maryland
    Centers for Medicare and Medicaid Services
Sep 21, 2023

Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

Recruiting
  • Alzheimer's Disease
    • Beijing, Beijing, China
      Xuanwu Hospital of Capital Medical University
    Nov 15, 2022

    The Diabetes Prevention Program Outcomes Study AD/ADRD Project

    Enrolling by invitation
    • Diabetes
    • +4 more
      • Phoenix, Arizona
      • +26 more
      Jan 19, 2023

      Can Pictures of Retina Detect Alzheimer's Disease at Its

      Enrolling by invitation
      • Alzheimer Disease
      • Mild Cognitive Impairment
      • Optical Coherence Tomography
      • Sacramento, California
        University of California - Davis
      Sep 5, 2023

      [18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's

      Recruiting
      • Alzheimer's Disease
      • Beijing, China
        Department of Nuclear Medicine, Peking Union Medical College Hop
      Nov 19, 2023

      Insomnia Trial in Kansas City (Cognitive Behavioral Therapy for Insomnia (CBT-I), Sleep and Lifestyle Education)

      Recruiting
      • Insomnia
      • Cognitive Behavioral Therapy for Insomnia (CBT-I)
      • Sleep and Lifestyle Education
      • Kansas City, Kansas
        University of Kansas Medical Center- Sleep, Health and Wellness
      Nov 1, 2022

      Cognitive Changes in Mild Cognitive Impairment

      Recruiting
      • Healthy Controls Without Orthostatic Hypotension
      • observational study
      • Fuzhou, Fujian, China
        Fujian Medical University Union Hospital
      Apr 6, 2023

      OCTA Factors in or Without Amyloid Pathology: A Prospective

      Completed
      • Alzheimer Disease
      • +4 more
        • Busan, Korea, Republic of
          Pusan National University Hospital
        Jul 24, 2022

        Renji Alzheimer's Disease Neuroimaging Cohort Study

        Enrolling by invitation
        • Alzheimer Disease
          • Shanghai, China
            Renji Hospital,Shanghai Jiao Tong University School of Medicine
          Jun 22, 2022

          Treatment, Efficacy, Safety Trial (Memantine Oral Tablet, GV-971 capsule)

          Not yet recruiting
          • Treatment
          • +3 more
          • Memantine Oral Tablet
          • GV-971 capsule
          • (no location specified)
          Jul 3, 2022

          Neuropathology, Cognitive Decline, Sleep Disorder Trial (procedure, behavioral, other)

          Not yet recruiting
          • Neuropathology
          • +2 more
          • Polysomnography
          • +4 more
          • (no location specified)
          Dec 5, 2022

          Transcutaneous Electrical Acupoint Stimulation, Postoperative Sleep Disturbances, Postoperative Cognitive Dysfunction Trial

          Not yet recruiting
          • Transcutaneous Electrical Acupoint Stimulation
          • +3 more
          • TEAS
          • control group
          • (no location specified)
          Apr 27, 2022

          Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial (Tafolecimab, Cholesterol Absorption Inhibitor,

          Not yet recruiting
          • Acute Coronary Syndrome
          • Non ST Segment Elevation Acute Coronary Syndrome
          • (no location specified)
          Oct 20, 2023

          Glaucoma Trial in United States (Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%)

          Active, not recruiting
          • Glaucoma
          • Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%
          • Mission Hills, California
          • +20 more
          Jan 6, 2023

          Alzheimer's Disease Trial in Fuzhou (18F-92)

          Recruiting
          • Alzheimer's Disease
          • Fuzhou, Fujian, China
            Department of Nuclear Medicine, First Affiliated Hospital of Fuj
          Nov 23, 2021

          Brain Stimulation, Alzheimer, tACS Trial in Hong Kong (High-definition transcranial current stimulation)

          Enrolling by invitation
          • Brain Stimulation
          • +5 more
          • High-definition transcranial current stimulation
          • Hong Kong, Hong Kong
            The Chinese University of Hong Kong
          Sep 14, 2022

          High Myopia, Glaucoma, Suspect Trial in Guangzhou (Assigned Interventions: IOP-lowering eye drops)

          Not yet recruiting
          • High Myopia
          • Glaucoma, Suspect
          • Assigned Interventions: IOP-lowering eye drops
          • Guangzhou, Guangdong, China
            Zhongshan Ophthalmic Center, Sun Yat-sen University
          Apr 29, 2023